Shuttle Pharmaceuticals (SHPH) Competitors $3.42 -0.10 (-2.84%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$3.47 +0.05 (+1.46%) As of 08/8/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. HCWB, BCLI, APLM, PPBT, GTBP, LIAN, SPRB, VYNE, ENSC, and BCTXShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include HCW Biologics (HCWB), Brainstorm Cell Therapeutics (BCLI), Apollomics (APLM), Purple Biotech (PPBT), GT Biopharma (GTBP), LianBio (LIAN), Spruce Biosciences (SPRB), VYNE Therapeutics (VYNE), Ensysce Biosciences (ENSC), and Briacell Therap (BCTX). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors HCW Biologics Brainstorm Cell Therapeutics Apollomics Purple Biotech GT Biopharma LianBio Spruce Biosciences VYNE Therapeutics Ensysce Biosciences Briacell Therap Shuttle Pharmaceuticals (NASDAQ:SHPH) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk. Does the media refer more to SHPH or HCWB? In the previous week, Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled HCW Biologics'average media sentiment score. Company Overall Sentiment Shuttle Pharmaceuticals Neutral HCW Biologics Neutral Which has preferable earnings and valuation, SHPH or HCWB? Shuttle Pharmaceuticals has higher earnings, but lower revenue than HCW Biologics. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than HCW Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-0.82HCW Biologics$2.57M2.59-$30.02M-$23.25-0.20 Is SHPH or HCWB more profitable? Shuttle Pharmaceuticals has a net margin of 0.00% compared to HCW Biologics' net margin of -1,712.94%. HCW Biologics' return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Shuttle PharmaceuticalsN/A -1,203.10% -370.42% HCW Biologics -1,712.94%N/A -90.09% Do insiders & institutionals have more ownership in SHPH or HCWB? 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. Comparatively, 3.0% of HCW Biologics shares are held by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are held by company insiders. Comparatively, 42.7% of HCW Biologics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, SHPH or HCWB? Shuttle Pharmaceuticals has a beta of -1.08, indicating that its stock price is 208% less volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Do analysts prefer SHPH or HCWB? HCW Biologics has a consensus price target of $35.00, suggesting a potential upside of 657.58%. Given HCW Biologics' stronger consensus rating and higher possible upside, analysts clearly believe HCW Biologics is more favorable than Shuttle Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryHCW Biologics beats Shuttle Pharmaceuticals on 9 of the 13 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.51M$2.41B$5.47B$9.71BDividend YieldN/A1.78%4.59%4.12%P/E Ratio-0.8220.3930.1024.70Price / SalesN/A725.92458.19100.35Price / CashN/A23.6624.8428.01Price / Book0.795.098.525.76Net Income-$9.15M$31.61M$3.27B$267.05M7 Day Performance-5.79%-2.02%4.65%3.13%1 Month Performance-14.07%-0.12%0.96%1.27%1 Year PerformanceN/A5.85%36.43%22.83% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals0.7497 of 5 stars$3.42-2.8%N/AN/A$1.51MN/A-0.825Gap UpHCWBHCW Biologics2.3464 of 5 stars$4.49+6.9%$35.00+679.5%-80.7%$6.46M$1.45M-0.1940Upcoming EarningsGap DownBCLIBrainstorm Cell Therapeutics1.6963 of 5 stars$0.58-16.0%N/A-85.1%$6.40MN/A-0.1740Upcoming EarningsAPLMApollomics0.0576 of 5 stars$5.72+3.1%N/A-64.7%$6.31MN/A0.0045PPBTPurple Biotech2.434 of 5 stars$2.26+2.3%$33.00+1,360.2%N/A$5.85MN/A-0.8620Earnings ReportUpcoming EarningsGTBPGT Biopharma2.1323 of 5 stars$1.77-0.6%$11.00+521.5%-16.4%$5.79MN/A-0.318Upcoming EarningsLIANLianBioN/A$0.05-2.4%N/A-84.6%$5.73MN/A-0.07110SPRBSpruce Biosciences1.9841 of 5 stars$0.14+12.5%$131.25+97,122.2%-69.6%$5.70M$4.91M-0.1420Negative NewsVYNEVYNE Therapeutics2.7375 of 5 stars$0.36-1.4%$6.25+1,635.6%-78.1%$5.48M$500K-0.3630Upcoming EarningsGap UpHigh Trading VolumeENSCEnsysce Biosciences0.4559 of 5 stars$2.23+3.7%N/A-61.2%$5.29MN/A-0.3410Upcoming EarningsBCTXBriacell Therap1.4905 of 5 stars$0.78+3.0%$32.00+4,014.2%-92.1%$5.27MN/A-0.098Stock Split Related Companies and Tools Related Companies HCWB Alternatives BCLI Alternatives APLM Alternatives PPBT Alternatives GTBP Alternatives LIAN Alternatives SPRB Alternatives VYNE Alternatives ENSC Alternatives BCTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale